Clinical trials
Phase 3 Hepatitis C trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
86 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 4 |
| 2003 | 1 |
| 2004 | 3 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 15 |
| 2012 | 11 |
| 2013 | 9 |
| 2014 | 11 |
| 2015 | 9 |
| 2016 | 3 |
| 2017 | 7 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 77 |
| Terminated | 7 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 20 |
| Bristol-Myers Squibb | 17 |
| AbbVie | 7 |
| Janssen R&D Ireland | 6 |
| Debiopharm International SA | 4 |
| GlaxoSmithKline | 4 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 4 |
| Janssen Infectious Diseases BVBA | 3 |
| Vertex Pharmaceuticals Incorporated | 3 |
| Boehringer Ingelheim | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 86 |
| Hepatitis C, Chronic | 21 |
| Fibrosis | 12 |
| Hepatitis | 8 |
| Liver Diseases | 8 |
| Virus Diseases | 5 |
| Bronchiolitis Obliterans Syndrome | 4 |
| Hepatitis, Chronic | 4 |
| Hepatitis, Viral, Human | 4 |
| Digestive System Diseases | 3 |
Trials
Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.